Alfavision Overseas (India) Limited (BOM:531156)
8.27
+0.03 (0.36%)
At close: Jun 19, 2026
BOM:531156 Revenue
In the fiscal year ending March 31, 2026, Alfavision Overseas (India) had annual revenue of 19.91M INR with 4.44% growth. Alfavision Overseas (India) had revenue of 6.61M in the quarter ending March 31, 2026.
Revenue
19.91M
Revenue Growth
+4.44%
P/S Ratio
13.10
Revenue / Employee
2.21M
Employees
9
Market Cap
260.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 19.91M | 846.00K | 4.44% |
| Mar 31, 2025 | 19.06M | -12.21M | -39.05% |
| Mar 31, 2024 | 31.27M | -276.84M | -89.85% |
| Mar 31, 2023 | 308.11M | -1.51B | -83.03% |
| Mar 31, 2022 | 1.82B | 24.74M | 1.38% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Kimia Biosciences | 1.15B |
| Smruthi Organics | 1.02B |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 357.23M |
| Link Pharma Chem | 274.32M |
| Crestchem | 266.14M |
| Krebs Biochemicals & Industries | 237.32M |